Paradigm Medical Industries, Inc. (PDMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
+0.0009 (900.00%)
At close: May 12, 2025
PDMI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2002 - 2006 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '12 Mar 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2002 - 2006 |
| Revenue | 0.76 | 0.77 | 0.73 | 0.86 | 1.26 | 1.87 | Upgrade
|
| Revenue Growth (YoY) | -5.02% | 6.34% | -15.38% | -31.85% | -32.75% | -14.71% | Upgrade
|
| Cost of Revenue | 0.23 | 0.25 | 0.31 | 0.41 | 0.7 | 1.02 | Upgrade
|
| Gross Profit | 0.53 | 0.53 | 0.42 | 0.45 | 0.56 | 0.85 | Upgrade
|
| Selling, General & Admin | 0.49 | 0.6 | 0.89 | 0.73 | 1.42 | 1.67 | Upgrade
|
| Research & Development | 0.25 | 0.26 | 0.36 | 0.24 | 0.26 | 0.34 | Upgrade
|
| Operating Expenses | 0.73 | 0.86 | 1.25 | 0.97 | 1.68 | 2.02 | Upgrade
|
| Operating Income | -0.21 | -0.33 | -0.83 | -0.52 | -1.12 | -1.17 | Upgrade
|
| Interest Expense | -0.15 | -0.15 | -0.16 | -0.44 | -0.83 | -0.99 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.02 | 0 | 0 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | - | 0.01 | 0.22 | 0.41 | Upgrade
|
| EBT Excluding Unusual Items | -0.35 | -0.47 | -0.97 | -0.95 | -1.73 | -1.73 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.09 | Upgrade
|
| Pretax Income | -0.35 | -0.47 | -0.97 | -0.95 | -1.73 | -1.64 | Upgrade
|
| Net Income | -0.35 | -0.47 | -0.97 | -0.95 | -1.73 | -1.64 | Upgrade
|
| Net Income to Common | -0.35 | -0.47 | -0.97 | -0.95 | -1.73 | -1.64 | Upgrade
|
| Shares Outstanding (Basic) | 5,359 | 4,640 | 46 | 11 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 5,359 | 4,640 | 46 | 11 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 5352.77% | 9893.07% | 314.25% | 9736.05% | 330.41% | 51.25% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.02 | -0.08 | -15.17 | -62.06 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.02 | -0.08 | -15.17 | -62.06 | Upgrade
|
| Free Cash Flow | 0.11 | -0.07 | -1.21 | -0.12 | -0.5 | -1.14 | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.03 | -0.01 | -4.42 | -42.87 | Upgrade
|
| Gross Margin | 69.88% | 68.01% | 57.16% | 52.45% | 44.08% | 45.51% | Upgrade
|
| Operating Margin | -27.08% | -42.75% | -114.88% | -60.84% | -89.12% | -62.29% | Upgrade
|
| Profit Margin | -45.57% | -61.40% | -133.33% | -110.72% | -137.33% | -87.77% | Upgrade
|
| Free Cash Flow Margin | 14.27% | -9.59% | -166.53% | -14.10% | -40.03% | -60.63% | Upgrade
|
| EBITDA | -0.2 | -0.33 | -0.83 | -0.52 | -1.12 | -1.16 | Upgrade
|
| EBITDA Margin | -26.95% | -42.62% | -114.33% | -60.72% | -88.72% | -62.02% | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| EBIT | -0.21 | -0.33 | -0.83 | -0.52 | -1.12 | -1.17 | Upgrade
|
| EBIT Margin | -27.08% | -42.75% | -114.88% | -60.84% | -89.12% | -62.29% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.